Close

Pfizer (PFE) Subsequent Tender Offer for Icagen (ICGN) Expires

September 20, 2011 8:12 AM EDT
Pfizer Inc. (NYSE: PFE) and Icagen, Inc. (Nasdaq: ICGN) announced today the expiration of the subsequent offering period of the cash tender offer by Pfizer’s wholly-owned subsidiary, Eclipse Acquisition Corp., for all of the outstanding shares of common stock of Icagen for $6.00 per share, paid to the seller in cash, without interest thereon, less any applicable withholding and transfer taxes.

The subsequent offering period expired at 6:00 p.m., New York City time, on Monday, September 19, 2011.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Mergers and Acquisitions